自助进行肿瘤基因变异的遗传咨询和用药指导
数据库整理的不错，还有中国肿瘤病患变异的真实案例，对自己的经验积累大大有益。
土拨鼠博士
Published by:
上海至本生物科技有限公司
Description
土拨鼠博士是至本医疗科技的数据共享和随访平台 APP，实现检测报 告在线查看，首家开放 OrigiMed 自主知识产权数据库，建立完整随 访系统和医医交互模式 :
1. 数据共享和随访平台：电子报告在线查看、核心基因一键查询、患 者随访 & 管理、统计分析、靶向免疫药物查询、临床试验。
2. 医生精准诊疗全程管理好帮手：最新文献解读、NGS 知识-至本学堂、 大咖学术视频、国内外专家精准治疗前沿观念。
3. 至本特色平台 ：OrigiMed Molecular Tumor Board、真实世 界研究、科研项目管理、在线病例讨论。
1. 数据共享和随访平台：电子报告在线查看、核心基因一键查询、患 者随访 & 管理、统计分析、靶向免疫药物查询、临床试验。
2. 医生精准诊疗全程管理好帮手：最新文献解读、NGS 知识-至本学堂、 大咖学术视频、国内外专家精准治疗前沿观念。
3. 至本特色平台 ：OrigiMed Molecular Tumor Board、真实世 界研究、科研项目管理、在线病例讨论。
Screenshots
土拨鼠博士 FAQ
-
Is 土拨鼠博士 free?
Yes, 土拨鼠博士 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 土拨鼠博士 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 土拨鼠博士 cost?
土拨鼠博士 is free.
-
What is 土拨鼠博士 revenue?
To get estimated revenue of 土拨鼠博士 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Russia yet.
Ratings History
土拨鼠博士 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
土拨鼠博士 Installs
Last 30 days
土拨鼠博士 Revenue
Last 30 days土拨鼠博士 Revenue and Downloads
Gain valuable insights into 土拨鼠博士 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 上海至本生物科技有限公司
- Languages
- English, Chinese
- Recent release
- 6.0.0 (11 months ago )
- Released on
- Sep 11, 2016 (8 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.